Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Therapeutic Nuclear Medicines Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis

2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact

3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies
5.1 Bracco Imaging S.p.A
5.1.1 Bracco Imaging S.p.A Company Profile
5.1.2 Bracco Imaging S.p.A Business Overview
5.1.3 Bracco Imaging S.p.A Therapeutic Nuclear Medicines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Bracco Imaging S.p.A Therapeutic Nuclear Medicines Products Introduction
5.2 GE Healthcare
5.2.1 GE Healthcare Company Profile
5.2.2 GE Healthcare Business Overview
5.2.3 GE Healthcare Therapeutic Nuclear Medicines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 GE Healthcare Therapeutic Nuclear Medicines Products Introduction
5.3 Bayer AG
5.3.1 Bayer AG Company Profile
5.3.2 Bayer AG Business Overview
5.3.3 Bayer AG Therapeutic Nuclear Medicines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Bayer AG Therapeutic Nuclear Medicines Products Introduction
5.4 Nordion, Inc.
5.4.1 Nordion, Inc. Company Profile
5.4.2 Nordion, Inc. Business Overview
5.4.3 Nordion, Inc. Therapeutic Nuclear Medicines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Nordion, Inc. Therapeutic Nuclear Medicines Products Introduction
5.5 Cardinal Health Inc.
5.5.1 Cardinal Health Inc. Company Profile
5.5.2 Cardinal Health Inc. Business Overview
5.5.3 Cardinal Health Inc. Therapeutic Nuclear Medicines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Cardinal Health Inc. Therapeutic Nuclear Medicines Products Introduction
5.6 IBA Molecular Imaging
5.6.1 IBA Molecular Imaging Company Profile
5.6.2 IBA Molecular Imaging Business Overview
5.6.3 IBA Molecular Imaging Therapeutic Nuclear Medicines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 IBA Molecular Imaging Therapeutic Nuclear Medicines Products Introduction
5.7 Advanced Accelerator Applications S.A.
5.7.1 Advanced Accelerator Applications S.A. Company Profile
5.7.2 Advanced Accelerator Applications S.A. Business Overview
5.7.3 Advanced Accelerator Applications S.A. Therapeutic Nuclear Medicines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Advanced Accelerator Applications S.A. Therapeutic Nuclear Medicines Products Introduction
5.8 Lantheus Medical Imaging Inc.
5.8.1 Lantheus Medical Imaging Inc. Company Profile
5.8.2 Lantheus Medical Imaging Inc. Business Overview
5.8.3 Lantheus Medical Imaging Inc. Therapeutic Nuclear Medicines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Lantheus Medical Imaging Inc. Therapeutic Nuclear Medicines Products Introduction
5.9 Mallinckrodt plc.
5.9.1 Mallinckrodt plc. Company Profile
5.9.2 Mallinckrodt plc. Business Overview
5.9.3 Mallinckrodt plc. Therapeutic Nuclear Medicines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Mallinckrodt plc. Therapeutic Nuclear Medicines Products Introduction
5.10 Eczacibasi-Monrol Nuclear Products
5.10.1 Eczacibasi-Monrol Nuclear Products Company Profile
5.10.2 Eczacibasi-Monrol Nuclear Products Business Overview
5.10.3 Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Products Introduction

6 Market Analysis and Forecast, By Product Types
6.1 Global Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Types (2015-2020)
6.1.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Types (2015-2020)
6.1.3 Global Therapeutic Nuclear Medicines Price by Types (2015-2020)
6.2 Global Therapeutic Nuclear Medicines Market Forecast by Types (2020-2025)
6.2.1 Global Therapeutic Nuclear Medicines Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Therapeutic Nuclear Medicines Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Therapeutic Nuclear Medicines Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Therapeutic Nuclear Medicines Sales, Price and Growth Rate of Beta Emitters
6.3.2 Global Therapeutic Nuclear Medicines Sales, Price and Growth Rate of Alpha Emitters
6.3.3 Global Therapeutic Nuclear Medicines Sales, Price and Growth Rate of Brachytherapy Products
6.4 Global Therapeutic Nuclear Medicines Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Beta Emitters Market Revenue and Sales Forecast (2020-2025)
6.4.2 Alpha Emitters Market Revenue and Sales Forecast (2020-2025)
6.4.3 Brachytherapy Products Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications
7.1 Global Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Applications (2015-2020)
7.1.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Applications (2015-2020)
7.2 Global Therapeutic Nuclear Medicines Market Forecast by Applications (2020-2025)
7.2.1 Global Therapeutic Nuclear Medicines Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Therapeutic Nuclear Medicines Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Therapeutic Nuclear Medicines Revenue, Sales and Growth Rate of Hospitals (2015-2020)
7.3.2 Global Therapeutic Nuclear Medicines Revenue, Sales and Growth Rate of Ambulatory Surgical Centers (2015-2020)
7.3.3 Global Therapeutic Nuclear Medicines Revenue, Sales and Growth Rate of Radiology Clinics (2015-2020)
7.4 Global Therapeutic Nuclear Medicines Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Hospitals Market Revenue and Sales Forecast (2020-2025)
7.4.2 Ambulatory Surgical Centers Market Revenue and Sales Forecast (2020-2025)
7.4.3 Radiology Clinics Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions
8.1 Global Therapeutic Nuclear Medicines Sales by Regions (2015-2020)
8.2 Global Therapeutic Nuclear Medicines Market Revenue by Regions (2015-2020)
8.3 Global Therapeutic Nuclear Medicines Market Forecast by Regions (2020-2025)

9 North America Therapeutic Nuclear Medicines Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Therapeutic Nuclear Medicines Market Sales and Growth Rate (2015-2020)
9.3 North America Therapeutic Nuclear Medicines Market Revenue and Growth Rate (2015-2020)
9.4 North America Therapeutic Nuclear Medicines Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Therapeutic Nuclear Medicines Market Analysis by Country
9.6.1 U.S. Therapeutic Nuclear Medicines Sales and Growth Rate
9.6.2 Canada Therapeutic Nuclear Medicines Sales and Growth Rate
9.6.3 Mexico Therapeutic Nuclear Medicines Sales and Growth Rate

10 Europe Therapeutic Nuclear Medicines Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Therapeutic Nuclear Medicines Market Sales and Growth Rate (2015-2020)
10.3 Europe Therapeutic Nuclear Medicines Market Revenue and Growth Rate (2015-2020)
10.4 Europe Therapeutic Nuclear Medicines Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Therapeutic Nuclear Medicines Market Analysis by Country
10.6.1 Germany Therapeutic Nuclear Medicines Sales and Growth Rate
10.6.2 United Kingdom Therapeutic Nuclear Medicines Sales and Growth Rate
10.6.3 France Therapeutic Nuclear Medicines Sales and Growth Rate
10.6.4 Italy Therapeutic Nuclear Medicines Sales and Growth Rate
10.6.5 Spain Therapeutic Nuclear Medicines Sales and Growth Rate
10.6.6 Russia Therapeutic Nuclear Medicines Sales and Growth Rate

11 Asia-Pacific Therapeutic Nuclear Medicines Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Therapeutic Nuclear Medicines Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Therapeutic Nuclear Medicines Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Therapeutic Nuclear Medicines Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Therapeutic Nuclear Medicines Market Analysis by Country
11.6.1 China Therapeutic Nuclear Medicines Sales and Growth Rate
11.6.2 Japan Therapeutic Nuclear Medicines Sales and Growth Rate
11.6.3 South Korea Therapeutic Nuclear Medicines Sales and Growth Rate
11.6.4 Australia Therapeutic Nuclear Medicines Sales and Growth Rate
11.6.5 India Therapeutic Nuclear Medicines Sales and Growth Rate

12 South America Therapeutic Nuclear Medicines Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Therapeutic Nuclear Medicines Market Sales and Growth Rate (2015-2020)
12.3 South America Therapeutic Nuclear Medicines Market Revenue and Growth Rate (2015-2020)
12.4 South America Therapeutic Nuclear Medicines Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Therapeutic Nuclear Medicines Market Analysis by Country
12.6.1 Brazil Therapeutic Nuclear Medicines Sales and Growth Rate
12.6.2 Argentina Therapeutic Nuclear Medicines Sales and Growth Rate
12.6.3 Columbia Therapeutic Nuclear Medicines Sales and Growth Rate

13 Middle East and Africa Therapeutic Nuclear Medicines Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Therapeutic Nuclear Medicines Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Therapeutic Nuclear Medicines Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Therapeutic Nuclear Medicines Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Therapeutic Nuclear Medicines Market Analysis by Country
13.6.1 UAE Therapeutic Nuclear Medicines Sales and Growth Rate
13.6.2 Egypt Therapeutic Nuclear Medicines Sales and Growth Rate
13.6.3 South Africa Therapeutic Nuclear Medicines Sales and Growth Rate

14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors

15 Appendix
15.1 Methodology
15.2 Research Data Source